Skip to main content

Bancel Stephane's Form 4 filing

Moderna, Inc. (MRNA) · filed Feb 24, 2023

Accession no.
0001127602-23-007042
Filed
Feb 24, 2023
Trade date
Feb 22-23, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 12 non-derivative transactions and 2 derivative transactions. Open-market sales total $12.2M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Bancel StephaneCIK 0001443340Director, Officer (Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 22, 2023Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Feb 22, 2023Common StockSSaleDisposed−10,472$157.87F2−$1,653,214.645,441,474Direct
Feb 22, 2023Common StockSSaleDisposed−20,303$158.53F3−$3,218,634.595,421,171Direct
Feb 22, 2023Common StockSSaleDisposed−8,725$159.59F4−$1,392,422.755,412,446Direct
Feb 22, 2023Common StockSSaleDisposed−500$160.28F5−$80,1405,411,946Direct
Feb 23, 2023Common StockMOption exerciseAcquired+40,000$0.99+$39,6005,451,946Direct
Feb 23, 2023Common StockSSaleDisposed−7,314$144.45F6−$1,056,507.35,444,632Direct
Feb 23, 2023Common StockSSaleDisposed−7,486$145.25F7−$1,087,341.55,437,146Direct
Feb 23, 2023Common StockSSaleDisposed−12,890$146.75F8−$1,891,607.55,424,256Direct
Feb 23, 2023Common StockSSaleDisposed−8,256$147.43F9−$1,217,182.085,416,000Direct
Feb 23, 2023Common StockSSaleDisposed−3,754$148.27F10−$556,605.585,412,246Direct
Feb 23, 2023Common StockSSaleDisposed−300$149.86F11−$44,9585,411,946Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 22, 2023Common StockMOption exerciseDisposed−40,000$0.00$01,427,155Direct
Feb 23, 2023Common StockMOption exerciseDisposed−40,000$0.00$01,387,155Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $157.13 to $158.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $158.14 to $159.14. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F4

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $159.15 to $160.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F5

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $160.19 to $160.42. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F6

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $143.81 to $144.80. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F7

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $144.84 to $145.79. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F8

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $146.03 to $147.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F9

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $147.04 to $148.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F10

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $148.05 to $148.76. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

F11

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $149.42 to $150.21. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)